Extracellular matrix inclusion in immunoisolating alginate-based microcapsules promotes longevity, reduces fibrosis, and supports function of islet allografts in vivo

  • Rei Kuwabara
  • , Tian Qin
  • , L. Alberto Llacua
  • , Shuxian Hu
  • , Mark Boekschoten
  • , Bart J. de Haan
  • , Alexandra M. Smink
  • , Paul de Vos

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Immunoisolation of pancreatic-islets in alginate-microcapsules is applied to treat diabetes. However, long-term islet function is limited, which might be due to damaged and lack of contact with pancreatic ex-tracellular matrix (ECM) components. Herein we investigated the impact of collagen IV combined with laminin sequences, either RGD, LRE, or PDSGR, on graft-survival of microencapsulated bioluminescent islets in vivo . Collagen IV with RGD had the most pronounced effect. It enhanced after 8-week implanta-tion in immune-incompetent mice the bioluminescence of allogeneic islets by 3.2-fold, oxygen consump-tion rate by 14.3-fold and glucose-induced insulin release by 9.6-fold. Transcriptomics demonstrated that ECM enhanced canonical pathways involving insulin-secretion and that it suppressed pathways related to inflammation and hypoxic stress. Also, 5.8-fold fewer capsules were affected by fibrosis. In a subse-quent longevity study in immune-competent mice, microencapsulated allografts containing collagen IV and RGD had a 2.4-fold higher functionality in the first week after implantation and remained at least 2.1-fold higher during the study. Islets in microcapsules containing collagen IV and RGD survived 211 +/- 24.1 days while controls survived 125 +/- 19.7 days. Our findings provide in vivo evidence for the efficacy of supplementing immunoisolating devices with specific ECM components to enhance functionality and longevity of islet-grafts in vivo . Statement of significance Limitations in duration of survival of immunoisolated pancreatic islet grafts is a major obstacle for appli-cation of the technology to treat diabetes. Accumulating evidence supports that incorporation of extra -cellular matrix (ECM) molecules in the capsules enhances longevity of pancreatic islets. After selection of the most efficacious laminin sequence in vitro , we show in vivo that inclusion of collagen IV and RGD in alginate-based microcapsules enhances survival, insulin secretion function, and mitochondrial function. It also suppresses fibrosis by lowering proinflammatory cytokines secretion. Moreover, transcriptomic anal-ysis shows that ECM-inclusion promotes insulin-secretion related pathways and attenuates inflammation and hypoxic stress related pathways in islets. We show that inclusion of ECM in immunoisolating devices is a promising strategy to promote long-term survival of islet-grafts. (c) 2023 The Authors. Published by Elsevier Ltd on behalf of Acta Materialia Inc. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
Original languageEnglish
Pages (from-to)151-162
Number of pages12
JournalActa Biomaterialia
Volume158
Early online dateFeb 2023
DOIs
Publication statusPublished - 1 Mar 2023
Externally publishedYes

Keywords

  • Alginate
  • Extracellular matrix
  • Islet transplantation
  • Microencapsulation
  • Type 1 diabetes

Fingerprint

Dive into the research topics of 'Extracellular matrix inclusion in immunoisolating alginate-based microcapsules promotes longevity, reduces fibrosis, and supports function of islet allografts in vivo'. Together they form a unique fingerprint.

Cite this